CXCL8 and neoplasm: MiR-302c/IL8 activates the RACK1-mediated receptor pathway to promote metastasis of gastric cancer [37], and low MiR-302c/IL8 expression is associated with invasion depth, tumor stage, and lymph node metastasis in gastric cancer [38].